Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Titlesort ascending Journal

Omar Abdel-Rahman

 June 2019 Asian Americans have better outcomes of non-metastatic gastric cancer compared to other United States racial groups: A secondary analysis from a randomized study World Journal of Gastrointestinal Oncology

Yu, Peter MD, ET AL

 February 2022 Artificial Intelligence Comes of Age in the Fight Against Cancer Oncology Times

Anne A. Eaton, Emily C. Zabor

 December 2021 Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules Statistics in Medicine

Yifei Sun, Xuming He, Jianhua Hu

 December 2022 An omnibus test for detection of subgroup treatment effects via data partitioning Annals of Applied Statistics

Wei-xiang Qi, Lu Cao, Cheng Xu, Shengguang Zhao, Jiayi Chen

 February 2020 Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials The Breast

Kirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, Oleg Stepanov, Nataliya Kudryashova, Gabriel Helmlinger, Kirill Peskov

 January 2022 A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics ASCPT

Leeann B Burton, Mahsa Eskian, Amanda C Guidon, Kerry L Reynolds

 November 2021 A review of neurotoxicities associated with immunotherapy and a framework for evaluation Neuro-Oncology Advances

Gerd Rippin, Nicolás Ballarini, Héctor Sanz, Joan Largent, Chantal Quinten & Francesco Pignatti

 July 2022 A Review of Causal Inference for External Comparator Arm Studies Springer Nature Switzerland AG

Sophia Z. Shalhout, Kevin S. Emerick, Howard E. Kaufman, David M. Miller

 June 2022 A retrospective study of ipilimumab plus nivolumab in anti–PD-L1/PD-1-refractory merkel cell carcinoma Journal of Clinical Oncology

Mehrad Mahmoudian, Fatemeh Seyednasrollah, Liisa Koivu, Outi Hirvonen, Sirkku Jyrkkio, Laura L. Elo

 May 2019 A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer F1000 Research

N. Geifman, A.J Butte

 May 2016 A Patient-Level Data Meta-Analysis of Standard-of-Care Treatments from Eight Prostate Cancer Clinical Trials Nature Scientific Data

Zhen Su, Monica M. Bertagnolli, A. Oliver Sartor, Catherine E. Symonds, Hao Zhang, Martin J. Murphy

 June 2018 A novel, open-access data commons for improved disease management in patients (pts) with Merkel cell carcinoma (MCC) Journal of Clinical Oncology

Zhen Su, Monica M. Bertagnolli, A. Oliver Sartor, Catherine E. Symonds, Hao Zhang, Martin J. Murphy

 June 2018 A novel, open-access data commons for improved disease management in patients (pts) with Merkel cell carcinoma (MCC) Journal of Clinical Oncology

Daniele Modonutti MD,Sami E. Majdalany MD,Nicholas Corsi BS,Pin Li PhD,Akshay Sood MD,Deepansh Dalela MD,Marcus L. Jamil MD,Clara Hwang MD,Mani Menon MD,Craig G. Rogers MD,Quoc-Dien Trinh MD,Giacomo Novara MD,Firas Abdollah MD

 July 2022 A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis The Prostate

Pages